Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director CC transcript Quarterly results Director departure Inv. presentation
|
NEOGENOMICS INC (NEO)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/03/2023 |
4
| Olivo Alicia C (General Counsel) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Paid exercise price by delivering 14 shares
@ $0 |
|
08/14/2023 |
4
| Perez David Brian (Director) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
08/14/2023 |
4
| Zook Anthony P. (Director) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
08/14/2023 |
4
| HANNAH ALISON L. (Director) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
08/14/2023 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
08/14/2023 |
4
| KANOVSKY STEPHEN M (Director) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
08/14/2023 |
4
| CROWTHER BRUCE K (Director) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
08/14/2023 |
4
| TETRAULT LYNN A. (Director) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
08/14/2023 |
4
| Floegel Elizabeth (Director) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
08/14/2023 |
4
| Gunn Neil (Director) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2023 |
4
| Sikri Vishal (President Advanced Diagnostics) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Paid exercise price by delivering 21,406 shares
@ $0 |
|
05/24/2023 |
4
| TETRAULT LYNN A. (Director) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Exercised 1,507 options to buy
@ $11.6, valued at
$17.5k
|
|
05/15/2023 |
4
| Smith Christopher M (CEO) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 269,841 options to buy
@ $19.65, valued at
$5.3M
Granted 144,190 restricted stock units
@ $0 Granted 144,190 rights
@ $0 |
|
05/15/2023 |
4
| Sherman Jeffrey Scott (CFO) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 73,016 options to buy
@ $19.65, valued at
$1.4M
Granted 39,016 restricted stock units
@ $0 Granted 39,016 rights
@ $0 |
|
05/15/2023 |
4
| Stone Warren (President, Clinical Services) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 53,969 options to buy
@ $19.65, valued at
$1.1M
Granted 28,838 restricted stock units
@ $0 Granted 21,204 rights
@ $0 |
|
05/15/2023 |
4
| Sikri Vishal (President Advanced Diagnostics) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 39,683 options to buy
@ $19.65, valued at
$779.8k
Granted 21,204 restricted stock units
@ $0 Granted 21,204 rights
@ $0 |
|
05/15/2023 |
4
| Harris Melody (President, Enterprise Ops) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 39,683 options to buy
@ $19.65, valued at
$779.8k
Granted 21,204 restricted stock units
@ $0 Granted 21,204 rights
@ $0 |
|
05/15/2023 |
4
| Olivo Alicia C (General Counsel) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 36,508 options to buy
@ $19.65, valued at
$717.4k
Granted 19,508 restricted stock units
@ $0 Granted 19,508 rights
@ $0 |
|
05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/04/2023 |
4
| Kulkarni Shashikant (Chief Scientific Officer) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Paid exercise price by delivering 3,759 shares
@ $0 |
|
01/04/2023 |
4
| Dieter Cynthia J (Chief Accounting Officer) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Paid exercise price by delivering 959 shares
@ $0 |
|
01/04/2023 |
4
| Harris Melody (President, Enterprise Ops) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 108,225 shares
@ $0 Granted 201,613 options to buy
@ $9.24, valued at
$1.9M
|
|
12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/07/2022 |
4
| Perez David Brian (Director) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 10,300 shares
@ $0 Granted 9,730 options to buy
@ $7.34, valued at
$71.4k
|
|
11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/03/2022 |
4
| Sholehvar David (President, Clinical Services) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 12,352 shares
@ $0 Granted 25,826 options to buy
@ $10.12, valued at
$261.4k
|
|
08/03/2022 |
4
| Kulkarni Shashikant (President of Lab Operations) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 24,704 shares
@ $0 Granted 51,653 options to buy
@ $10.12, valued at
$522.7k
|
|
06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2022 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 15,556 shares
@ $0 Granted 13,882 options to buy
@ $8.1, valued at
$112.4k
|
|
06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2022 |
4
| CROWTHER BRUCE K (Director) has filed a Form 4 on NEOGENOMICS INC
Txns:
| Granted 15,556 shares
@ $0 Granted 13,882 options to buy
@ $8.1, valued at
$112.4k
|
|
|
|
|